| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Jan―21 |
The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review |
Farnoosh Nozari, Nasrin Hamidizadeh, Salvatore Corrao |
| 2 |
[GO] |
2021―Dec―20 |
Hypertension May Reduce the Infection Risk but Increase the Severity of COVID-19: Based on the Current Data in China |
Bo Li, Lu Zeng, Nengjun Sun, Yunhe Zhao, Faming Zhao, Hongjun Bian, et al. (+5) Wei Yi, Jing Yang, Bin Li, Guohai Su, Kwok Leung Ong |
| 3 |
[GO] |
2021―Oct―19 |
Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension |
Leila Moftakhar, Elahe Piraee, Mohammad Mohammadi Abnavi, Parisa Moftakhar, Habibollah Azarbakhsh, Aliasghar Valipour, Massimo Salvetti |
| 4 |
[GO] |
2021―Mar―22 |
The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients |
Pedro Gaspar, Inês Parreira, Pedro Antunes Meireles, Filipe Bessa, Virgílio Dias Silva, Ana Mafalda Abrantes, et al. (+3) António Pais de Lacerda, Catarina Mota, Thereza Maria Moreira Thereza Maria |
| 5 |
[GO] |
2020―Dec―05 |
Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology |
Alexander Kamyshnyi, Inna Krynytska, Victoriya Matskevych, Mariya Marushchak, Oleh Lushchak, Masayoshi Soma |
| 6 |
[GO] |
2020―Oct―21 |
Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts |
Kunal Mahajan, Prakash Chand Negi, Neeraj Ganju, Sachin Sondhi, Naresh Gaur, Rao Somendra, Tomohiro Katsuya |
|
